US Patent 8513244 Neprilysin inhibitors
Patent 8513244 was granted and assigned to Theravance on August, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 Sep, 2023
Golden AI
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08513244 Neprilysin inhibitors US Patent 8513244 Neprilysin inhibitors
Infobox
Patent Number
08513244
Patent Number
8513244
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08513244 Neprilysin inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08513244
Date of patent
August 20, 2013
Patent application number
13474987
Date Filed
May 18, 2012
Patent primary examiner
Find more entities like US Patent 8513244 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
